Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Onabotulinumtoxina

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China Approves First Recombinant Botulinum Toxin A Drug
    China Approves First Recombinant Botulinum Toxin A Drug

    28 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/worlds-first-recombinant-botulinum-toxin-type-a-new-drug-received-marketing-approval-in-china-a-technological-revolution-pioneered-by-claruvis-pharmaceutical-302755457.html

    PR NEWSWIRE
    28 Apr 2026
    Share Share
    Sisram Medical Completes NIFDC Testing For DAXXIFY In China
    Sisram Medical Completes NIFDC Testing For DAXXIFY In China

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sisram-medical-reports-completion-of-nifdc-testing-for-daxxify-in-china-302652501.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    FDA Warns Companies On Illegal Marketing Of Botox & Related
    FDA Warns Companies On Illegal Marketing Of Botox & Related

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181870/0/en/FDA-Warns-Companies-Over-Illegal-Marketing-of-Botox-and-Related-Products.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    BOTOX® Cosmetic Launches 'The One & Only' Campaign with Stories
    BOTOX® Cosmetic Launches 'The One & Only' Campaign with Stories

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/botox-cosmetic-onabotulinumtoxina-unveils-the-one--only-campaign-featuring-real-people-and-their-distinctive-stories-302550142.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    Hugel Debuts Botulinum Toxin Letybo in Malaysia
    Hugel Debuts Botulinum Toxin Letybo in Malaysia

    10 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hugel-launches-botulinum-toxin-letybo-in-malaysia-302525192.html

    PR NEWSWIRE
    10 Aug 2025
    Share Share
    Botox Cosmetic Picks Entrepreneurs for Confidence Project
    Botox Cosmetic Picks Entrepreneurs for Confidence Project

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/botox-cosmetic-onabotulinumtoxina-selects-this-years-entrepreneurs-for-the-confidence-project-302510168.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.